Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    6815536 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Suspended Phase II Trial of LMB-2, Fludarabine and Cyclophosphamide for Adult T-Cell Leukemia
Condition: Adult T-Cell Leukemia (ATL)
Interventions: Drug: LMB-2;   Drug: Fludarabine;   Drug: Cyclophosphamide

Indicates status has not been verified in more than two years